All Stories

  1. A randomized trial of safety, pharmacokinetics and pharmacodynamics of concizumab in people with hemophilia A

    Article • Journal of Thrombosis and Haemostasis, September 2018, Wiley

    Professor Paul Knoebl, Dr Victor Jimenez-Yuste

  2. High proportion of patients with bleeding of unknown cause in persons with a mild-to-moderate bleeding tendency: Results from the Vienna Bleeding Biobank (VIBB)

    Article • Haemophilia, February 2018, Wiley

    Professor Paul Knoebl

  3. Intensive consolidation with G-CSF support: Tolerability, safety, reduced hospitalization, and efficacy in acute myeloid leukemia patients ≥60 years

    Article • American Journal of Hematology, August 2017, Wiley

    Professor Paul Knoebl

  4. Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpura

    Article • Journal of Thrombosis and Haemostasis, June 2017, Wiley

    Professor Paul Knoebl

  5. Acquired hemophilia A: Updated review of evidence and treatment guidance

    Article • American Journal of Hematology, June 2017, Wiley

    Professor Paul Knoebl

  6. Safety and pharmacokinetics of anti‐ TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial

    Article • Journal of Thrombosis and Haemostasis, April 2015, Wiley

    Professor Paul Knoebl

  7. NET untangled in TMA?

    Article • Journal of Thrombosis and Haemostasis, April 2015, Wiley

    Professor Paul Knoebl

  8. Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study

    Article • Blood, December 2014, American Society of Hematology

    Professor Paul Knoebl

  9. Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humans

    Article • Blood, December 2014, American Society of Hematology

    Professor Paul Knoebl

  10. A novel flow‐based assay reveals discrepancies in ADAMTS‐13 inhibitor assessment as compared with a conventional clinical static assay

    Article • Journal of Thrombosis and Haemostasis, September 2014, Elsevier

    Professor Paul Knoebl

  11. Prognostic factors, long-term survival, and outcome of cancer patients receiving chemotherapy in the intensive care unit

    Article • Annals of Hematology, July 2014, Springer Science + Business Media

    Professor Paul Knoebl

  12. Inherited and Acquired Thrombotic Thrombocytopenic Purpura (TTP) in Adults

    Article • Seminars in Thrombosis and Hemostasis, May 2014, Thieme Publishing Group

    Professor Paul Knoebl

  13. Immune-Mediated Disorders Causing Bleeding or Thrombosis in Lymphoproliferative Diseases

    Article • Seminars in Thrombosis and Hemostasis, March 2014, Thieme Publishing Group

    Professor Paul Knoebl

  14. Extracorporeal membrane oxygenation in adult patients with hematologic malignancies and severe acute respiratory failure

    Article • Critical Care, January 2014, Springer Science + Business Media

    Professor Paul Knoebl

  15. Spezielle Probleme beim Intensivpatienten

    Article • January 2014, Springer Science + Business Media

    Professor Paul Knoebl

  16. Hepatic dysfunction contributes to coagulation disturbances in patients undergoing whole body hyperthermia by use of extracorporeal circulation

    Article • The International Journal of Artificial Organs, January 2014, Wichtig

    Professor Paul Knoebl

  17. Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura

    Article • Haematologica, November 2013, Ferrata Storti Foundation (Haematologica)

    Professor Paul Knoebl

  18. Treatment of thrombotic microangiopathy with a focus on new treatment options

    Article • Hämostaseologie, January 2013, Schattauer GmbH

    Professor Paul Knoebl

  19. Hereditary thrombotic thrombocytopenic purpura and the hereditary TTP registry

    Article • Hämostaseologie, January 2013, Schattauer GmbH

    Professor Paul Knoebl

  20. Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry

    Article • BJOG An International Journal of Obstetrics & Gynaecology, August 2012, Wiley

    Professor Paul Knoebl, Dr Nuria Bermejo

  21. Inhibition of tissue factor pathway inhibitor by the aptamer BAX499 improves clotting of hemophilic blood and plasma

    Article • Journal of Thrombosis and Haemostasis, August 2012, Elsevier

    Professor Paul Knoebl

  22. Difficult clinical challenges in haemophilia: international experiential perspectives

    Article • Haemophilia, July 2012, Wiley

    Professor Gili Kenet, Professor Paul Knoebl

  23. The anti-von Willebrand factor aptamer ARC1779 increases von Willebrand factor levels and platelet counts in patients with type 2B von Willebrand disease

    Article • Thrombosis and Haemostasis, June 2012, Schattauer GmbH

    Professor Paul Knoebl

  24. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry

    Article • Blood, May 2012, American Society of Hematology

    Professor Paul Knoebl, Dr Nuria Bermejo

  25. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)

    Article • Blood, April 2012, American Society of Hematology

    Professor Paul Knoebl, Dr Nuria Bermejo

  26. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)

    Article • Journal of Thrombosis and Haemostasis, March 2012, Wiley

    Professor Paul Knoebl, Dr Nuria Bermejo

  27. Initial experience from a double-blind, placebo-controlled, clinical outcome study of ARC1779 in patients with thrombotic thrombocytopenic purpura

    Article • American Journal of Hematology, February 2012, Wiley

    Professor Paul Knoebl

  28. Primäre Immunthrombozytopenie des Erwachsenen – Diagnostik und Therapie, Konsensus-Statement der Österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO)

    Article • Wiener klinische Wochenschrift, February 2012, Springer Science + Business Media

    Professor Paul Knoebl

  29. Inverse correlation of free and immune complex-sequestered anti-ADAMTS13 antibodies in a patient with acquired thrombotic thrombocytopenic purpura

    Article • Journal of Thrombosis and Haemostasis, January 2012, Wiley

    Professor Paul Knoebl

  30. Comparison of enoxaparin and unfractionated heparin in endovascular interventions for the treatment of peripheral arterial occlusive disease: a randomized controlled trial

    Article • Journal of Thrombosis and Haemostasis, November 2011, Wiley

    Professor Paul Knoebl

  31. A dose ranging phase I/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with congenital thrombotic thrombocytopenic purpura

    Article • Thrombosis and Haemostasis, August 2011, Schattauer GmbH

    Professor Paul Knoebl

  32. Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies

    Article • Journal of Thrombosis and Haemostasis, May 2011, Wiley

    Professor Paul Knoebl

  33. Postoperative paraneoplastic factor VIII auto-antibodies in patients with solid tumours

    Article • Haemophilia, March 2011, Wiley

    Professor Paul Knoebl

  34. Whole body hyperthermia by extracorporeal circulation in spontaneously breathing sarcoma patients: Hemodynamics and oxygen metabolism

    Article • The International Journal of Artificial Organs, January 2011, Wichtig

    Professor Paul Knoebl

  35. Inhibition of von Willebrand factor by ARC1779 in patients with acute thrombotic thrombocytopenic purpura

    Article • Thrombosis and Haemostasis, December 2010, Schattauer GmbH

    Professor Paul Knoebl, Professor Jolanta M Siller-Matula

  36. The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients

    Article • International Journal of Antimicrobial Agents, December 2010, Elsevier

    Professor Paul Knoebl

  37. A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease

    Article • Thrombosis and Haemostasis, June 2010, Schattauer GmbH

    Professor Paul Knoebl

  38. Blood coagulation disorders in septic patients

    Article • Wiener Medizinische Wochenschrift, March 2010, Springer Science + Business Media

    Professor Paul Knoebl

  39. The aptamer ARC1779 blocks von Willebrand factor-dependent platelet function in patients with thrombotic thrombocytopenic purpura ex vivo

    Article • Transfusion, January 2010, Wiley

    Professor Paul Knoebl, Professor Jolanta M Siller-Matula

  40. Evaluation of in vivo antineoplastic effects of rapamycin in patients with chemotherapy-refractory AML

    Article • European Journal of Internal Medicine, December 2009, Elsevier

    Professor Paul Knoebl

  41. Anti-von Willebrand factor aptamer ARC1779 for refractory thrombotic thrombocytopenic purpura

    Article • Transfusion, October 2009, Wiley

    Professor Paul Knoebl

  42. Nonpegylated liposomal doxorubicin is highly active in patients with B and T/NK cell lymphomas with cardiac comorbidity or higher age

    Article • Annals of Hematology, July 2009, Springer Science + Business Media

    Professor Paul Knoebl

  43. The effect of interferon alpha on myeloproliferation and vascular complications in polycythemia vera

    Article • European Journal Of Haematology, April 2009, Wiley

    Professor Paul Knoebl

  44. Immunosuppressive treatment for acquired haemophilia: current practice and future directions in Germany, Austria and Switzerland

    Article • Annals of Hematology, December 2008, Springer Science + Business Media

    Professor Paul Knoebl

  45. Severe congenital protein C deficiency: the use of protein C concentrates (human) as replacement therapy for life-threatening blood-clotting complications

    Article • Biologics Targets & Therapy, June 2008, Dove Medical Press

    Professor Paul Knoebl

  46. PCR-monitoring of minimal residual leukaemia after conventional chemotherapy and bone marrow transplantation in BCR-ABL-positive acute lymphoblastic leukaemia

    Article • British Journal of Haematology, March 2008, Wiley

    Professor Paul Knoebl

  47. Safety and efficacy of intravenous enoxaparin for carotid endarterectomy: A prospective randomized pilot trial

    Article • Journal of Vascular Surgery, March 2008, Elsevier

    Professor Paul Knoebl

  48. Plasma levels of P-selectin are determined by platelet turn-over and the P-selectin Thr715Pro polymorphism

    Article • Thrombosis Research, January 2008, Elsevier

    Professor Paul Knoebl

  49. Human protein C concentrates for replacement therapy in congenital and acquired protein C deficiency

    Article • January 2008, Prous Science

    Professor Paul Knoebl

  50. Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy

    Article • European Journal of Clinical Investigation, October 2007, Wiley

    Professor Paul Knoebl

  51. Is there an association between hemostatic abnormalities and the outcome of acute lung injury?*

    Article • Critical Care Medicine, August 2007, Wolters Kluwer Health

    Professor Paul Knoebl

  52. THE EFFECT OF PROTEIN C REPLACEMENT ON COAGULOPATHY IN ADULTS WITH INFECTIOUS PURPURA FULMINANS.

    Article • Critical Care Medicine, December 2006, Wolters Kluwer Health

    Professor Paul Knoebl

  53. Unraveling the immunologic response in thrombotic thrombocytopenic purpura

    Article • Journal of Thrombosis and Haemostasis, November 2006, Wiley

    Professor Paul Knoebl

  54. Treatment of adult patients with sepsis-induced coagulopathy and purpura fulminans using a plasma-derived protein C concentrate (CeprotinR)

    Article • Vox Sanguinis, May 2006, Wiley

    Professor Paul Knoebl

  55. Antiplatelet therapy prior to carotid endarterectomy – still room for improvement

    Article • VASA, May 2006, Hogrefe Publishing Group

    Professor Paul Knoebl

  56. The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia

    Article • Thrombosis and Haemostasis, November 2005, Schattauer GmbH

    Professor Paul Knoebl

  57. Respiratory failure after stem cell transplantation: Improved outcome with non-invasive ventilation

    Article • Leukemia & Lymphoma, August 2005, Taylor & Francis

    Professor Paul Knoebl

  58. Brief Report: Practicability and safety of amphotericin B deoxycholate as continuous infusion in neutropenic patients with hematological malignancies

    Article • Leukemia & Lymphoma, August 2005, Taylor & Francis

    Professor Paul Knoebl

  59. High dose intermittent ARA-C (HiDAC) for consolidation of patients with de novo AML: a single center experience

    Article • Leukemia Research, June 2005, Elsevier

    Professor Paul Knoebl

  60. On the Evaluation of the ISTH Score for Overt Disseminated Intravascular Coagulation

    Article • Critical Care Medicine, May 2005, Wolters Kluwer Health

    Professor Paul Knoebl

  61. Antithrombotic Strategies in Vascular Surgery: Evidence and Practice

    Article • European Journal of Vascular and Endovascular Surgery, May 2005, Elsevier

    Professor Paul Knoebl, Professor Ojan Assadian

  62. Predicting the course of sepsis: The next step?*

    Article • Critical Care Medicine, February 2005, Wolters Kluwer Health

    Professor Paul Knoebl

  63. Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation

    Article • Thrombosis and Haemostasis, January 2005, Schattauer GmbH

    Professor Paul Knoebl

  64. Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosis

    Article • Thrombosis Research, January 2005, Elsevier

    Professor Paul Knoebl

  65. Stability of coagulation factors in thawed, solvent/detergent-treated plasma during storage at 4 oC for 6 days

    Article • Vox Sanguinis, October 2004, Wiley

    Professor Paul Knoebl

  66. Fibrin sealant produced by the CryoSealR FS System: product chemistry, material properties and possible preparation in the autologous preoperative setting

    Article • Vox Sanguinis, May 2004, Wiley

    Professor Paul Knoebl

  67. Evaluation of an end-tidal portable ETCO2 colorimetric breath indicator (COLIBRI)

    Article • The American Journal of Emergency Medicine, January 2004, Elsevier

    Professor Paul Knoebl

  68. Impact of cytogenetics on the prognosis of adults with de novo AML in first relapse

    Article • Leukemia, December 2003, Springer Science + Business Media

    Professor Paul Knoebl

  69. Myocardial involvement in a patient with Burkitt's lymphoma mimicking hypertrophic cardiomyopathy

    Article • Journal of the American Society of Echocardiography, December 2003, Elsevier

    Professor Paul Knoebl

  70. Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb® immunoadsorption

    Article • Bone Marrow Transplantation, November 2003, Springer Science + Business Media

    Professor Paul Knoebl

  71. Is the determination of anti-beta2 glycoprotein I antibodies useful in patients with venous thromboembolism without the antiphospholipid syndrome?

    Article • British Journal of Haematology, October 2003, Wiley

    Professor Paul Knoebl

  72. Efficacy and tolerability of non-invasive ventilation delivered via a newly developed helmet in immunosuppressed patients with acute respiratory failure

    Article • Wiener klinische Wochenschrift, September 2003, Springer Science + Business Media

    Professor Paul Knoebl

  73. Treatment concepts for elderly patients with acute myeloid leukemia

    Article • Wiener klinische Wochenschrift, August 2003, Springer Science + Business Media

    Professor Paul Knoebl

  74. Pathophysiologie und Therapie von Sepsis-assoziierten Gerinnungsstorungen

    Article • Wiener Medizinische Wochenschrift, November 2002, Wiley

    Professor Paul Knoebl

  75. Factors affecting long-term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult patients reported to the Austrian Stem Cell Transplantation Registry

    Article • British Journal of Haematology, June 2002, Wiley

    Professor Paul Knoebl

  76. Frequent development of lupus anticoagulants in critically ill patients treated under intensive care conditions

    Article • Critical Care Medicine, April 2002, Wolters Kluwer Health

    Professor Paul Knoebl

  77. Treatment of acquired factor viii autoantibodies by immunoadsorption

    Article • British Journal of Haematology, September 2001, Wiley

    Professor Paul Knoebl

  78. Impact of the factor II: G20210A variant on the risk of venous thromboembolism in relatives from families with the factor V: R506Q mutation

    Article • European Journal Of Haematology, September 2001, Wiley

    Professor Paul Knoebl

  79. Platelet-reactive HLA antibodies associated with low posttransfusion platelet increments:a comparison between the monoclonal antibody-specific immobilization of platelet antigens assay and the lymphocytotoxicity test

    Article • Transfusion, June 2001, Wiley

    Professor Paul Knoebl

  80. Prospective Monitoring of Minimal Residual Disease in Acute Myeloid Leukemia with Inversion(16) by CBFβ/MYH11 RT-PCR: Implications for a Monitoring Schedule and for Treatment Decisions

    Article • Leukemia & Lymphoma, January 2001, Taylor & Francis

    Professor Paul Knoebl

  81. Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb)

    Article • British Journal of Haematology, January 2001, Wiley

    Professor Paul Knoebl

  82. Prognosis of patients with a second relapse of acute myeloid leukemia

    Article • Leukemia, December 2000, Springer Science + Business Media

    Professor Paul Knoebl

  83. Local anticoagulation of the extracorporeal circuit with heparin and subsequent neutralization with protamine during immunoadsorption

    Article • American Journal of Kidney Diseases, September 2000, Elsevier

    Professor Paul Knoebl

  84. Prostaglandin E1 does not influence plasmatic coagulation, hepatic synthesis, or postoperative blood loss in patients after coronary-artery bypass grafting

    Article • Journal of Clinical Anesthesia, August 2000, Elsevier

    Professor Paul Knoebl

  85. Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems

    Article • Transfusion, May 2000, Wiley

    Professor Paul Knoebl

  86. The ?typical? immunophenotype of acute promyelocytic leukemia (APL-M3): Does it prove true for the M3-variant?

    Article • Cytometry, April 2000, Wiley

    Professor Paul Knoebl

  87. The “typical” immunophenotype of acute promyelocytic leukemia (APL‐M3): Does it prove true for the M3‐variant?

    Article • Cytometry, April 2000, Wiley

    Professor Paul Knoebl

  88. Prolonged Third Remission in a Patient With Acute Promyelocytic Leukemia After Consolidation Chemotherapy With Intermittent Intermediate Dose Ara-C and Maintenance With Intermittent all-transRetinoic Acid (ATRA)

    Article • Leukemia & Lymphoma, January 2000, Taylor & Francis

    Professor Paul Knoebl

  89. Die Immunadsorption zur Behandlung von Gerinnungsinhibitoren: Ergebnisse der Wiener Gruppe

    Article • January 2000, Springer Science + Business Media

    Professor Paul Knoebl

  90. Immunologic recovery of patients given CD34-selected peripheral blood progenitor cell transplantation for malignant diseases

    Article • Bone Marrow Transplantation, January 2000, Springer Science + Business Media

    Professor Paul Knoebl

  91. Homocysteine levels in polycythaemia vera and essential thrombocythaemia

    Article • British Journal of Haematology, May 1999, Wiley

    Professor Paul Knoebl

  92. Homocysteine levels in polycythaemia vera and essential thrombocythaemia

    Article • British Journal of Haematology, May 1999, Wiley

    Professor Paul Knoebl

  93. Post-transplant acute myeloid leukemia (PT-AML)

    Article • Leukemia, March 1999, Springer Science + Business Media

    Professor Paul Knoebl

  94. Extracorporeal Immunoadsorption for the Treatment of Haemophilic Patients with Inhibitors to Factor VIII or IX

    Article • Vox Sanguinis, January 1999, Wiley

    Professor Paul Knoebl

  95. Hypofibrinogenemia in non-M3 acute myeloid leukemia. Incidence, clinical and laboratory characteristics and prognosis

    Article • Leukemia, August 1998, Springer Science + Business Media

    Professor Paul Knoebl

  96. Recombinant human megakaryocyte growth and development factor increases levels of circulating haemopoietic progenitor cells post chemotherapy in patients with acute myeloid leukaemia

    Article • British Journal of Haematology, July 1998, Wiley

    Professor Paul Knoebl

  97. 2 Acquired factor V inhibitors

    Article • Baillière s Clinical Haematology, June 1998, Elsevier

    Professor Paul Knoebl

  98. Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donors

    Article • Bone Marrow Transplantation, March 1998, Springer Science + Business Media

    Professor Paul Knoebl

  99. Elimination von erworbenen Gerinnungsinhibitoren mit extrakorporaler Immunadsorption (Ig-Therasorb)

    Article • January 1998, Springer Science + Business Media

    Professor Paul Knoebl

  100. Therapie der thrombotisch-thrombozytopenischen Purpura (TTP) bei kritisch kranken Patienten

    Article • January 1998, Springer Science + Business Media

    Professor Paul Knoebl

  101. 80 Phenotypic analysis of endosteal cells in myelodysplastic syndromes and other hemopoietic disorders

    Article • Leukemia Research, April 1997, Elsevier

    Professor Paul Knoebl

  102. Prostaglandin E sub 1 Inhibits Platelet Decrease after Massive Blood Transfusions during Major Surgery

    Article • March 1997, Wolters Kluwer Health

    Professor Paul Knoebl

  103. Specificities of anti-platelet antibodies in multitransfused patients with haemato-oncological disorders

    Article • British Journal of Haematology, December 1996, Wiley

    Professor Paul Knoebl

  104. ORAL CONTRACEPTIVES ENHANCE THE RISK OF CLINICAL MANIFESTATION OF VENOUS THROMBOSIS AT A YOUNG AGE IN FEMALES HOMOZYGOUS FOR FACTOR V LEIDEN

    Article • British Journal of Haematology, May 1996, Wiley

    Professor Paul Knoebl

  105. MICROANGIOPATHY FOLLOWING ALLOGENEIC MARROW TRANSPLANTATION ASSOCIATION WITH CYCLOSPORINE AND METHYLPREDNISOLONE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS

    Article • Transplantation, November 1995, Wolters Kluwer Health

    Professor Paul Knoebl

  106. MICROANGIOPATHY FOLLOWING ALLOGENEIC MARROW TRANSPLANTATION ASSOCIATION WITH CYCLOSPORINE AND METHYLPREDNISOLONE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS

    Article • Transplantation, November 1995, Wolters Kluwer Health

    Professor Paul Knoebl

  107. Rapid elimination of a high-titer spontaneous factor V antibody by extracorporeal antibody-based immunoadsorption and immunosuppression

    Article • Annals of Hematology, October 1995, Springer Science + Business Media

    Professor Paul Knoebl

  108. Kinetics of minimal residual disease during induction/consolidation therapy in standard-risk adult B-lineage acute lymphoblastic leukemia

    Article • Annals of Hematology, October 1995, Springer Science + Business Media

    Professor Paul Knoebl

  109. Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus

    Article • The American Journal of Medicine, May 1995, Elsevier

    Professor Paul Knoebl

  110. Dexverapamil as resistance modifier in acute myeloid leukaemia

    Article • Journal of Cancer Research and Clinical Oncology, March 1995, Springer Science + Business Media

    Professor Paul Knoebl

  111. High efficacy of the German multicenter ALL (GMALL) protocol for treatment of adult acute lymphoblastic leukemia (ALL) — a single-institution study

    Article • Annals of Hematology, October 1994, Springer Science + Business Media

    Professor Paul Knoebl

  112. PML-RARα PCR positivity in the bone marrow of patients with APL precedes haematological relapse by 2–3 months

    Article • British Journal of Haematology, October 1994, Wiley

    Professor Paul Knoebl

  113. Ventilation With the Combitube During Tracheotomy

    Article • The Laryngoscope, June 1994, Wiley

    Professor Paul Knoebl

  114. Apolipoprotein (a) Levels and Atherogenic Lipid Fractions in Relation to the Degree of Urinary Albumin Excretion in Type 2 Diabetes mellitus

    Article • January 1994, Karger Publishers

    Professor Paul Knoebl

  115. R-metHuG-CSF Combined with Chemotherapy for Treatment of Adult ALL — Pilot Study

    Article • January 1994, Springer Science + Business Media

    Professor Paul Knoebl

  116. Thrombogenic factors are related to urinary albumin excretion rate in Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetic patients

    Article • Diabetologia, October 1993, Springer Science + Business Media

    Professor Paul Knoebl

  117. Effectivity of Combituben™ in patient with cardiac arrest

    Article • Resuscitation, February 1993, Elsevier

    Professor Paul Knoebl

  118. 079 Lipid peroxidation products in diabetics

    Article • January 1992, Springer Science + Business Media

    Professor Paul Knoebl

  119. Diagnostic Value of Hemostatic Parameters for Prediction of Complications in Patients Undergoing Aorto-Coronary Bypass Grafting

    Article • January 1991, Springer Science + Business Media

    Professor Paul Knoebl

  120. The effect of near-normoglycaemic control on plasma levels of coagulation factor VII and the anticoagulant proteins C and S in insulin-dependent diabetic patients

    Article • British Journal of Haematology, November 1989, Wiley

    Professor Paul Knoebl

  121. Replacement therapy for a homozygous protein C deficiency-state using a concentrate of human protein C and S

    Article • British Journal of Haematology, December 1988, Wiley

    Professor Paul Knoebl

  122. Quantitative determination of human protein C evaluation of a “fast” functional assay in comparison to a “traditional” functional and an immunological assay

    Article • Thrombosis Research, January 1988, Elsevier

    Professor Paul Knoebl

  123. Whole blood aggregometry and platelet adenine nucleotides during cardiac surgery

    Article • Scandinavian Journal of Thoracic and Cardiovascular Surgery, January 1988, Taylor & Francis

    Professor Paul Knoebl

  124. Plasma levels of protein C and protein S in patients with vasculopathy

    Article • Thrombosis Research, March 1987, Elsevier

    Professor Paul Knoebl

  125. Treatment of Adults with Sepsis-Induced Coagulopathy and Purpura Fulminans with a Plasma-Derived Protein C Concentrate (Ceprotin)

    Article • Springer Science + Business Media

    Professor Paul Knoebl